Viking Global Investors
Stamford
Find your way into Viking Global Investors
What they invest in
from 39 of 48 portfolio companiesBiotech ×18Healthtech ×13SaaS ×11AI & Machine Learning ×8Enterprise Software ×6Digital Health ×4Fintech ×4Advanced Manufacturing ×3
HQs:United States×36Brazil×1France×1United Kingdom×1Sweden×1
Investments · 48 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 42024 · 62023 · 62022 · 52021 · 52020 · 42019 · 22018 · 12017 · 12015 · 239 dated
4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.
BiotechHealthtechEmeryville, US
David Kirn(Executive Officer, Director)inDavid Schaffer(Director)inTheresa Janke(Executive Officer)in
BoardSharon Tetlow(Director)Margi McLoughlin(Director)
Co-investorsAmzak HealthBerkeley CatalystBOLD LongevityChiesi VenturesPappas CapitalPfizer Venture Investments+3 more
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.
BiotechHealthtechMedical DevicesSan Diego, US
Paul Schimmel(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)Frederic Chereau(Executive Officer)
BoardAmir Nashat(Non-Management Director)inAkkaraju Srinivas(Non-Management Director)
Co-investorsCardinal PartnersEcoR1 CapitalSofinnova VenturesDomain PartnersPolaris PartnersSamsara BioCapital
Domo offers a cloud-based platform that integrates data integration, analytics, automation, and artificial intelligence capabilities to help organizations connect data sources, prepare and analyze information, and automate business processes and workflows.
Enterprise SoftwareSaaSAmerican Fork, US
Josh James(Founder, Chairman & CEO)inShane Atchison(Executive Officer)inMatt Belkin(Executive Officer)inBruce Felt(Executive Officer)inDaren Thayne(Chief Technology Officer & Executive Vice President of Product)inTod Crane(Chief Financial Officer)in
Co-investorsAndreessen HorowitzBlackRockCapital GroupGlynn Capital ManagementGreylock PartnersIVP (Institutional Venture Partners)+6 more
Allonnia applies industrial biology—screening microbes and engineered proteins that interact with metals—to recover copper, nickel, and rare earths from ore and mine waste streams like coal ash, tailings, and acid mine drainage.
BiotechCleantechNew MaterialsBoston, US
Nicole Richards(CEO)inKent Sorenson(Chief Technology Officer)inChuck(Executive)inPamela(Head of Human Resources)inHugh(Financial Leadership)in
BoardTom Biegala(Director)in
Co-investorsBison VenturesBHP VenturesFerment StudioGeneral AtlanticVale Ventures
AlphaSense provides a financial research and market intelligence platform that combines standardized financials, consensus estimates, filings, earnings transcripts, broker research, and AI-generated answers for analyzing and benchmarking companies.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechNew York, US
Rajmohan Neervannan(Related person at the time of the offering.)Jaakko Kokko(Related person at the time of the offering.)inRaj Neervannan(Chief Technology Officer & Co-Founder)inJaakko (Jack) Kokko(Founder)inJack Kokko(Chief Executive Officer & Founder)inKiva Kolstein(President & Chief Revenue Officer)in
Co-investorsAlkeon InnovationCapitalGCentana Growth PartnersSoftBank Vision FundTriangle Peak PartnersTribeca Venture Partners+5 more
Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.
BiotechChapel Hill, US
Robin Walker(Executive Officer)inChristopher Courts(Executive Officer)inJorge Bartolome(Executive Officer, Director)in
BoardBenjamin Gomez(Director)Adam Koppel(Director)inMichael E. Bozik(Director)
Co-investorsARCH Venture PartnersBain Capital Life SciencesGV (Google Ventures)Access BiotechnologyMaverick CapitalSaturn Partners
AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.
Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US
William Zell(Executive Officer, Director)William Ruff(Executive Officer)inRobert Lee(Director)inTad Dritz(VP of Development)inJeff Haskett(COO)inBrian Graham(Executive Officer, Director)in
Co-investorsCerity Partners VenturesG2 Venture PartnersHarmonic Growth PartnersJobsOhio VenturesMonte Carlo CapitalOUP (Osage University Partners)+4 more
Green Island, US
Eben Bayer(Executive Officer, Director)inPatricia Strickland(Executive Officer)Stephen Lomnes(Executive Officer)in
BoardShally Shanker(Director)inStephen McDonnell(Director)Jessica Harris(Director)
Co-investorsUnovis Asset ManagementAiiM PartnersFootPrint CoalitionStray Dog Capital
Auris Gestion is an independent asset management firm offering asset allocation and wealth management services across three activities serving independent financial advisors and family offices, institutional clients, and private clients.
Fintech
Co-investorsAndera PartnersCoatue ManagementLux CapitalMithril Capital Management
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesAthosCivilization Ventures Management, LlcGlobal Health Investment CorporationIn-Q-TelSherpalo Ventures
Advanced ManufacturingAgTechBrisbane, US
Jamie Bacher(Founder)inAdam Paul Arkin(Founder)in
BoardErkki Aaltonen(Director)in
Co-investorsCompoundKickstart InnovationSaltagen VenturesUniversal Materials IncubatorY CombinatorYara Growth Ventures+1 more
Cazoo is a UK online used-car marketplace and classified advertising business, now owned by MOTORS after its 2024 administration.
London, GB
Co-investorsAutotech VenturesCherry VenturesDIP CapitalEight Roads VenturesEntrée CapitalSapphire Ventures+3 more
Cloudbeds provides a property management system (PMS) and growth platform for hospitality businesses, including hotels and other accommodations.
Cloud ComputingPropTechSaaSTravel & Hospitality
Co-investorsClearVision EquityCounterpart VenturesMoore Venture PartnersPeakSpan Capital PartnersSoftBank Vision FundCultivation Capital+1 more
Color Health operates a nationwide virtual cancer clinic delivering oncologist-led care, screening, and treatment management for employer, union, health plan, and public sector populations.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Othman Laraki(CEO)in
Co-investors8VCComcast VenturesCRV (Charles River Ventures)Dria VenturesForesite CapitalHomebrew+9 more
Deciphera is a pharmaceutical company focused on developing treatments for people living with cancer.
Biotech
Daniel Flynn(Founder)in
Co-investorsFrazier Life SciencesNew Leaf Venture PartnersREDMILE
BiotechWaltham, US
Daniel F. Flynn, Ph.D.(Executive Officer)Oliver Rosen, M.D.(Executive Officer)inThomas Kelly(Executive Officer)Michael Taylor(Executive Officer, Director)in
BoardMichael Ross(Director)Liam Ratcliffe, M.D., Ph.D.(Director)
Co-investorsFrazier Life SciencesREDMILE
Dock provides a white-label customer portal platform that enables companies to manage projects, share files, track engagement, and handle renewals in a single collaborative workspace.
AI & Machine LearningEnterprise SoftwareSaaSSales Tech
Co-investorsFjor FoundersOperator CollectiveRecall CapitalHearst VenturesLightbankLinse Capital+3 more
Dock provides cloud-native payments and banking infrastructure that lets companies offer digital accounts, branded (white label) cards, Pix, acquiring, and anti-fraud/identity verification services.
Data & InfrastructureFintechSaaS
Co-investorsConfraparRiverwood Capital
Dock is a collaborative workspace where users create teams of specialized AI agents that coordinate with one another to carry out departmental work.
AI & Machine LearningEnterprise SoftwareSan Francisco, US
Govind Kavaturi(Co-Founder)inMike Molinet(Founder)in
Co-investorsVela PartnersY CombinatorHearst VenturesLightbankLinse CapitalMatter Venture Partners+2 more
Druva provides a cloud-native SaaS platform for data backup, protection, recovery, and AI-driven data insights across enterprise data and workloads.
Cloud ComputingCybersecuritySaaSSunnyvale, US
Milind Borate(Director)inJaspreet Singh(Founder & CEO)inMahesh Patel(Executive Officer)inEugenia Buzogly(Executive Officer)
BoardShailendra Jit Singh(Director)inJishnu Bhattacharjee(Director)in
Co-investorsArbor Ventures UKFounders Circle CapitalHercules Capital, Inc.Orios Venture PartnersPeak XV PartnersRiverwood Capital+8 more
Ecovative grows whole-cut meat alternatives and other materials from mycelium using its AirMycelium indoor cultivation platform, which integrates with existing mushroom farming infrastructure.
BiotechFoodTechNew MaterialsGreen Island, US
Gavin McIntyre(Executive Officer, Director)Eben Bayer(Executive Officer, Director)in
BoardEvan Lodes(Director)Jerry Weinstein(Director)Charles Deull(Director)Jessica Harris(Director)
Co-investorsBreakout LabsBreakout VenturesStray Dog CapitalAiiM PartnersFootPrint CoalitionStandard Investments
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+7 more
Envise provides interactive real estate solutions and property management tools for real estate companies and their customers throughout the property lifecycle.
PropTechSaaS
Anna Nordström(CEO)in
Co-investorsRound2 Capital PartnersFidelity InvestmentsGV (Google Ventures)T. Rowe Price
Biotech company developing antibodies to treat autoimmune and inflammatory diseases.
Co-investorsArkin CapitalJeito CapitalMonograph Capital PartnersAlpha Wave GlobalARCH Venture Partners
Keboola provides a data platform that helps organizations turn data into reliable decisions.
AI & Machine LearningClimate TechCloud ComputingData & InfrastructureFintechSaaS
Petr Simecek(Founder)in
Co-investorsPresto VenturesReflex CapitalTCF Capital
.jpg)
BiotechSan Diego, US
Stephen W. Kaldor(Executive Officer, Director, Promoter)Eric Murphy(Executive Officer, Director)
BoardBret Zbar(Director)Carl Gordon(Director)Michael Rome(Director)in
Co-investorsForesite CapitalNextech InvestJanus Henderson InvestorsRA CapitalVenrock Healthcare Capital Partners
Lightmatter is a product development firm that partners with companies to design and build digital products from concept through launch.
Developer ToolsHealthtechSaaSMountain View, US
Greg Hausheer(CEO and Founder)inBen Beecher(CTO and Founder)inNicholas Harris(Founder)inThomas Graham(Founder)inTrevor Moorman(COO)inMollie Fleury(Chief of Staff)in
Co-investorsGV (Google Ventures)Spark CapitalFidelity InvestmentsT. Rowe Price
AdmitHub provides AI-powered success coaching and conversation tools for higher education institutions to improve student engagement, retention, and outcomes.
AI & Machine LearningEdTechHR TechArlington, US
Andrew Magliozzi(Founder)in
Co-investorsFundersClubMichelson 20MM FoundationNXT VenturesTechstarsAlly Bridge GroupFountain Healthcare Partners+3 more
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)inJason Hannonin
BoardManus Rogan(Director)inAntoine Papiernik(Director)in
Co-investorsFountain Healthcare PartnersSofinnova PartnersAlly Bridge GroupGilde Healthcare
San Francisco, US
Catherine Planey(Executive Officer, Director)Alexander Mok(Executive Officer, Director)
BoardFrancisco Gimenez(Director)in
Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.
BiotechDeep TechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)
Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+7 more
Pearl Health provides tools, intelligence, and support to primary care providers and healthcare organizations to deliver proactive care within value-based care models.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechNew York, US
Michael Kopko(Board Member, CEO)in
BoardJeffrey De Flavio(Executive Chairman)inVineeta Agarwala(Director)inScott Kupor(Director)inJeff DeFlavio(Director)inKevin Ryan(Director)in
Co-investorsAndreessen HorowitzAlleyCorpAlumni VenturesBasecamp FundFloating PointSV Angel+2 more
Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia.
BiotechHealthtechWellness & FitnessWaltham, US
ILISSA LARIMORE(Executive Officer)GERARDO TOLEDO(Executive Officer, Director)ERIC SCHOTT(Executive Officer)
BoardANULA JAYASURIYA(Director)inMATTHEW WALKER(Director)inNEAL BHADKAMKAR(Director)in
Co-investorsOlive Tree CapitalRising TideBold Capital PartnersDigitalDx VenturesGISEV Family OfficeS2G Investments
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesAgent Capital+9 more
Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.
BiotechDigital HealthHealthtech
Co-investorsAtlas VentureBorealis VenturesBorealis VenturesMagnetic VenturesOrbiMedAscenta Capital+3 more
Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.
HealthtechMedical DevicesSaaS
Co-investorsHarbor Light Capital PartnersMountain Group CapitalClayton Dubilier & RiceHLM Venture PartnersRock Springs CapitalSequoia Heritage
Vitagene offers at-home test kits that analyze DNA, inflammation markers, and other health indicators, delivering results online in plain language.
Digital HealthDirect to ConsumerHealthtechWellness & FitnessSan Francisco, US
Mehdi Maghsoodnia(Executive Officer, Director)inReza Malek(Executive Officer, Director)
BoardLyon Wong(Director)
Co-investorsBabel Ventures
Voyado provides AI-powered customer engagement, product discovery, and loyalty solutions for retailers to increase revenue.
AI & Machine LearningMarketing TechRetail TechSaaSNorrköping, SE
Mikael Selegård(Founder)inErica Sandelin Ekelundin
Co-investorseEquity ABVerdane
BiotechSan Francisco, US
Kaz Ohno(Executive Officer)James Lim(Executive Officer)Brian S. Feth(Executive Officer, Director)
BoardSaeid Akhtari(Director)
Co-investorsCasdin CapitalDynamk CapitalFormic Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AmplifyBioAuris Surgical RoboticsBiome MakersEpiBiomeGT Medical TechnologiesHumanevaJazzwarePavia SystemsTalaris Therapeutics
Exits · 5
3 IPOs · 2 acquisitions · showing 44D Molecular TherapeuticsNASDAQ: FDMTaTYR PHARMANASDAQ: ATYRDomoNASDAQ: DOMOHI-Bioacq. by Biogen
Portfolio news
latest coverage across their companiesDock · globenewswire.com · Sep 10, 2026
Jazzware · investing.com · Aug 25, 2026
Kinnate Biopharma · labusinessjournal.com · Aug 17, 2026
Triveni · fiercebiotech.com · Aug 12, 2026
Domo · utahbusiness.com · Aug 11, 2026
AlphaSense · industry-lens.com · Aug 11, 2026
Fund performance · per public LP disclosures
as of Dec 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Viking Global Equities LPLPs: Texas Municipal Retirement System | — | — | — | 0.99x | — |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| aTYR PHARMA | 4.8% | $4.25 | Feb 2020 | $1.7M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Viking Global Investors made?
- Viking Global Investors has 48 tracked investments, 5 of which have exited, including 9 dated in the last 24 months.
- Where is Viking Global Investors located?
- Viking Global Investors is headquartered in Stamford, US.
- Does Viking Global Investors lead rounds?
- Viking Global Investors has led 12 of the 39 rounds where its role is on record.
- Who does Viking Global Investors co-invest with?
- Viking Global Investors most often shares deals with Andreessen Horowitz, Glynn Capital Management, Greylock Partners, among 9 tracked co-investors.